In case you saw the story we posted about AgriLabs recent announcement about FluNix-D for use in lactating dairy cows you might want to read this update.

AgriLabsR recently announced the United States Food and Drug Administration (FDA) approval of FluNix-D (flunixin meglumine) for use in lactating dairy cows. FluNix-D is a Non-Steroidal Anti-Inflammatory Drug (NSAID) that provides producers with a safe and effective support therapy for their dairy cows by reducing the fever and inflammation caused by Bovine Respiratory Disease (BRD) and endotoxemia. The announcement stated that FluNix-D could be administered intravenously or intramuscularly. It should have stated that the product can only be administered intravenously in lactating dairy cows. FluNix-D is not approved for intramuscular administration in lactating dairy cows. FluNix-D has a 36-hour milk withdrawal and four-day meat withdrawal in lactating dairy cows.